Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $11.03 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.